Epigenetics Market to Value at $4.1 Billion by 2030, With CAGR of 14.8%: States Allied Market Research

The global epigenetics market is driven by factors such as surging number of R & D activities, increase in genome mapping programs, growth in prevalence of cancer, and latest technological advancements associated with epigenetics.

Wilmington, Delaware, Nov. 14, 2023 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Epigenetics Market by Product (Kits, Reagents, Enzymes, Instruments), by Application (Oncology, Non Oncology), by End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2020-2030.” As per the latest report published by Allied Market Research, the global market for epigenetics is estimated to value at $4.1 billion by 2030. The market generated revenue of $1.0 billion in 2020 and is anticipated to witness the fastest growth with 14.8% CAGR from 2021 to 2030. 

Factors influencing the growth of the market: 

The global epigenetics market is driven by factors such as surging number of R & D activities, increase in genome mapping programs, growth in prevalence of cancer, and latest technological advancements associated with epigenetics. However, lack of skilled professionals and standardization concerns over epigenetics-derived diagnostics restrain the market growth to some extent. Nevertheless, numerous growth prospects in the emerging economies are expected to provide ample growth opportunities to the key players in the industry.  

Request Sample of the Report on Epigenetics Market Forecast 2032 –  https://www.alliedmarketresearch.com/request-sample/846 

The kits segment to rule the roost 

In terms of products, the kits segment grabbed the largest market share of nearly two-fifths of the global epigenetics market in 2020. The growth is attributed to the availability of a diverse range of kits. However, the instruments segments is expected to portray the fastest growth with 16.3% CAGR from 2021 to 2030, owing to launch and development of several instruments for epigenetic purposes.  

Recent Developments in the Epigenetics Market 

  • In February 2021, Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform announced the launch of the Twist NGS Methylation Detection System, a robust, end-to-end sample preparation and target enrichment solution for identifying methylated regions in the human genome. 
  • In March 2021, Hologic, Inc., a global leader in women’s health, it has acquired the Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products, for approximately $159 million (130 million euros), subject to working capital and other customary closing adjustments. 
  • In January 2023, Agilent Technologies Inc. announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to study cancer. Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine. 

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/846 

The oncology segment to grab the lion’s share by 2030 

In terms of application, the oncology segment accounted for the highest share of more than two-thirds of the total market revenue in 2020. The growing prevalence of cancer across the world accelerates the growth of the segment. However, the non-oncology segment would cite the fastest growth with 15.3% CAGR throughout the forecast timeframe. The growth is attributed to surge in chronic diseases specifically metabolic and cardiac disorders. 

North America generated the major share in 2020 

According to the regional analysis, the North America region acquired the major market share in 2020, due to presence of frontrunners and speedy adoption of advanced technologies across the region. Asia-Pacific, on the other hand, is anticipated to showcase the fastest growth with 16.3% CAGR during the forecast period, owing to surge in healthcare investment and surge in R & D activities across the region.  

For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/846 

Leading Market Players:

  • Thermo Fisher Scientific Inc. 
  • Hologic Inc. 
  • Active Motif, Inc. 
  • Illumina Inc. 
  • Agilent Technologies, Inc. 
  • Merck Millipore 
  • QIAGEN N.V. 
  • Zymo Research 
  • PerkinElmer, Inc. 
  • Abcam Plc.  

Comprehensive Healthcare Industry Research Studies: 

Medical Gas Analyzers Market Expected to Reach $325 Million by 2025 

Antibiotics Market Expected to Reach $50,374 Million by 2025 

Healthcare Chatbot Market Expected to Reach $116.9 Million by 2026 

Pharmaceutical Filtration Market Expected to Reach $7.74 Billion by 2026 

Drug Delivery Devices Market Expected to Reach $26.7 Billion by 2026 

Artificial Cornea and Corneal Implant Market Expected to Reach $656.19 Million by 2028   

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 


Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.